$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Do I need to take Ixazomib/Enleri for a long time?
2026-02-01 22:25:32
Check Details
Taking ixazomib/Enleri can keep the condition stable for several years
2026-02-01 22:25:32
Check Details
What is the regimen of ixazomib/Enleri combined with lenalidomide?
2026-02-01 22:25:32
Check Details
Sparsentin: feasibility study for long-term treatment of chronic kidney disease
2026-02-01 22:25:32
Check Details
Is there any difference in the effect of sparsentane on patients of different age groups?
2026-02-01 22:25:32
Check Details
How is the dosage and frequency of sparsentane determined?
2026-02-01 22:25:32
Check Details
Can spaxentan be used with other medications?
2026-02-01 22:25:32
Check Details
Overview of key monitoring indicators during molotinib treatment
2026-02-01 22:25:32
Check Details
Is molotinib available on the market in China?
2026-02-01 22:25:32
Check Details
Molotinib dosage, side effects, precautions
2026-02-01 22:25:32
Check Details
Molotinib is a new drug for the treatment of primary myelofibrosis
2026-02-01 22:25:32
Check Details
How long can you take crizotinib for lung adenocarcinoma?
2026-02-01 22:25:32
Check Details
1
2
...
1078
1079
1080
1081
1082
1083
1084
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
2
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
3
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
4
Eltrombopag Administration Timing and Alternative Therapy Guide
5
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
6
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
7
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
8
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
9
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
10
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
11
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
12
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison